Drug Detail

Information about Berzosertib

Generic Name
 Berzosertib
IND
 M6620
Brand Name (US)
Manufacturer
 Merck
Drug Type
Delivery
 Intravenous
Approval Status
Indications
Overall Strategy
 Block DNA damage repair
Strategy
 Inhibit ATR enzyme
Drug Category
 SDH-directed

Links

Trials of this drug

  

 M6620 (VX-970) in Selected Solid Tumors
   

Trial results
  CCR 10/25/2024 "A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors"
   

Search for this drug/combination in:

ClinicalTrials.gov

ASCO

Pubmed